Description
J147 Powder Nootropics also known as (N-(2,4-Dimethylphenyl)-2,2,2-trifluoro-N-(3-methoxy-E-phenylmethyliden)acetamid), is a compound that is being researched for its potential use as a treatment for Alzheimer’s disease and dementia.
J147 Powder Nootropics is a very potent and selective antagonist of the α7 nicotinic acetylcholine receptor with an IC50 of 0.4 nM in cells expressing this receptor. When administered orally to mice it has been shown to increase brain levels of both BDNF and GDNF by approximately 2 fold.
Reviews
There are no reviews yet.